Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ACGL✓SelectedUSD · ACGLMRNA vs ACGL performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs ACGL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+152.4%
ACGL return
+36.1%
Excess return
+116.4%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioACGLExcessAlpha
1D+1.3%-0.4%+1.7%+1.3%
7D-13.8%-1.0%-12.9%-13.9%
30D-17.7%+6.8%-24.4%-17.1%
3M+14.3%+9.8%+4.5%+15.4%
6M+336.0%+12.2%+323.8%+339.9%
YTD+575.9%+12.8%+563.2%+580.7%
1Y+724.4%+18.6%+705.7%+726.3%
All+152.4%+36.1%+116.4%+148.6%

Cumulative growth

Daily Returns

Daily percentage return beside ACGL.

Daily Out/Under-Performance

Portfolio return minus ACGL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ACGL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded ACGL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling